Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)

PHASE3CompletedINTERVENTIONAL
Enrollment

351

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
MigraineMigraine Disorders
Interventions
DRUG

sumatriptan succinate/naproxen sodium

Trial Locations (35)

10021

GSK Investigational Site, New York

10022

GSK Investigational Site, New York

15106

GSK Investigational Site, Carnegie

19114

GSK Investigational Site, Philadelphia

27103

GSK Investigational Site, Winston-Salem

29464

GSK Investigational Site, Mt. Pleasant

32127

GSK Investigational Site, Port Orange

33351

GSK Investigational Site, Sunrise

33407

GSK Investigational Site, West Palm Beach

37203

GSK Investigational Site, Nashville

45069

GSK Investigational Site, West Chester

45245

GSK Investigational Site, Cincinnati

45267

GSK Investigational Site, Cincinnati

46601

GSK Investigational Site, South Bend

48104

GSK Investigational Site, Ann Arbor

60614

GSK Investigational Site, Chicago

68134

GSK Investigational Site, Omaha

70808

GSK Investigational Site, Baton Rouge

73104

GSK Investigational Site, Oklahoma City

77054

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

78626

GSK Investigational Site, Georgetown

80304

GSK Investigational Site, Boulder

80909

GSK Investigational Site, Colorado Springs

84109

GSK Investigational Site, Salt Lake City

85224

GSK Investigational Site, Chandler

87108

GSK Investigational Site, Albuquerque

90277

GSK Investigational Site, Redondo Beach

90404

GSK Investigational Site, Santa Monica

92618

GSK Investigational Site, Irvine

94109

GSK Investigational Site, San Francisco

97210

GSK Investigational Site, Portland

98195

GSK Investigational Site, Seattle

43614-5809

GSK Investigational Site, Toledo

02886

GSK Investigational Site, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY